(-)-Ambrox Crystallization for Scalable Bioconversion Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing (-)-Ambrox, a valuable fragrance ingredient, are inefficient, costly, and lack scalable and environmentally friendly processes, particularly in separating and purifying it from bioconversion media containing impurities and by-products.
Innovation Solution
A crystalline form of (-)-Ambrox is formed in a biocatalytic process, allowing for efficient separation and purification through size separation steps like filtration and decantation, utilizing the physical characteristics of the crystals to isolate olfactively pure (-)-Ambrox.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If bioconversion of homofarnesol to (-)-Ambrox is performed using SHC enzyme, then (-)-Ambrox can be produced, but the reaction mixture contains complex impurities and by-products that are difficult to separate and purify
Solution Approach 1:
The patent employs crystallization (a phase transition from liquid/dissolved state to solid crystal state) to separate (-)-Ambrox from the complex reaction mixture. The (-)-Ambrox crystallizes as colorless elongate crystals with specific morphology, allowing physical separation from impurities and by-products in the bioconversion medium through filtration or decantation.
Solution Approach 2:
The invention exploits the unique physical characteristics of (-)-Ambrox crystals (colorless, elongate shape, specific size range) that differ from the surrounding impurities and by-products. This local quality difference enables selective separation based on crystal morphology and physical properties rather than requiring complex chemical purification.
2Manufacturing precision
If conventional purification methods like distillation or column chromatography are used, then (-)-Ambrox can be purified, but the process becomes complex and not industrially scalable
Solution Approach 1:
The patent extracts (-)-Ambrox from the complex bioconversion medium by inducing crystallization, where the target compound separates out as discrete crystals. This physical extraction method replaces complex chemical purification techniques like column chromatography with a simple filtration or decantation step, reducing device complexity while maintaining purity.
Solution Approach 2:
The invention changes physical parameters (temperature, solvent composition, pH) of the bioconversion medium to induce crystallization of (-)-Ambrox. By adjusting these parameters, the solubility of (-)-Ambrox is reduced while impurities remain dissolved, enabling simple physical separation instead of complex purification procedures.
3Productivity
If microbial biocatalysts are used for bioconversion, then the process is environmentally friendly and scalable, but the medium contains cellular material and off-note characteristics that complicate purification
Solution Approach 1:
The patent uses crystallization to separate (-)-Ambrox from the microbial bioconversion medium. The crystalline form of (-)-Ambrox physically separates from cellular material and other medium components, effectively removing off-note characteristics associated with the microbial biocatalyst while maintaining the environmental benefits of the bioconversion process.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A solid form of (-)-Ambrox formed by a bioconversion process.